Updated on 2026/04/05

写真a

 
Muto Yoshinori
 
Organization
Graduate Faculty of Interdisciplinary Research Faculty of Medicine Clinical Medicine (Dermatology) Assistant Professor
Title
Assistant Professor
External link

Research History

  • University of Yamanashi   department of dermatology   Assistant Professor   Major achievement

    2021.5

  • University of Yamanashi   Assistant Professor

    2021.5

  • University of Yamanashi   Clinical Assistant Professor

    2020.4 - 2021.4

  • University of Yamanashi   Clinical Assistant Professor

    2020.4 - 2021.4

  • 山梨厚生病院   皮膚科   専攻医

    2019.10 - 2020.3

  • 山梨県立中央病院   皮膚科   専攻医

    2019.4 - 2019.9

  • 山梨大学医学部附属病院   皮膚科   専攻医

    2018.4 - 2019.3

  • さいたま赤十字病院   麻酔科

    2014.7 - 2018.3

  • 東京大学医学部附属病院   麻酔科・痛みセンター   後期研修医

    2013.4 - 2014.6

  • 高知県立あき総合病院   内科

    2012.10 - 2013.3

  • Jichi Medical University

    2010.4 - 2012.9

▼display all

Education

  • University of Yamanashi

    2004.4 - 2010.3

    　 More details

    Country： Japan

  • University of Yamanashi   Faculty of Medicine   School of Medicine

    2004.4 - 2010.3

    　 More details

    Country： Japan

  • University of Yamanashi

    2019.4

Degree

  • 学士（医学） ( 山梨大学 )

Research Areas

  • Life Science / Dermatology

  • Life Science / Immunology

Research Interests

  • 皮膚免疫

Papers

  • Comprehensive Melanoma-Related Gene Analysis of Bilateral Diffuse Uveal Melanocytic Proliferation: A Case Report. Reviewed

    Yoshinori Muto, Youichi Ogawa, Masataka Kawai, Keisuke Goto, Shinji Shimada, Tatsuyoshi Kawamura

    International journal of dermatology   2026.1( ISSN：0011-9059  eISSN：1365-4632 )

    　More details

    Authorship：Lead author   Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1111/ijd.70284

    PubMed

  • Antitumor Effect of Selumetinib for Brainstem Glioma in an Adult With NF1: A Case Report Reviewed

    Ryu Saito, Mitsuto Hanihara, Takashi Okamoto, Maiko Fujihara, Yoshinori Muto, Hirofumi Kazama, Kunio Mochizuki, Hideyuki Yoshioka, Hiroyuki Kinouchi

    Neurosurgery Practice   6 ( 4 )   2025.10( ISSN：2834-4383  eISSN：2834-4383 )

    　More details

    Language：English   Publishing type：Research paper (scientific journal)   Publisher：Ovid Technologies (Wolters Kluwer Health)  

    BACKGROUND AND IMPORTANCE:

    NF1 is a known tumor predisposition syndrome associated with various tumors of the nervous system, including low-grade glioma in the pediatric population. NF1-associated brainstem tumors are less clinically progressive and rarely result in early death. However, a small subset of brainstem gliomas may act more aggressively in adults, especially when contrast enhancement appears. However, standard therapy for NF1-associated brainstem glioma remains controversial, and there is limited information available on the pathological and genetic findings.

    CLINICAL PRESENTATION:

    A 38-year-old man presented with diplopia and was diagnosed with a midbrain tumor on MRI. The tumor increased in size during a 2-month follow-up period, and the patient underwent an open biopsy by the occipital transtentorial approach. Histopathological diagnosis revealed a low-grade glioma, isocitrate dehydrogenase wild type, and H3 wild type. An NF1 mutation was detected using a cancer gene panel test. The MAPK kinase inhibitor, selumetinib, was prescribed as first-line treatment. The patient achieved a good clinical response, with impressive radiological regression of the disease and no major adverse events. After 6 months of selumetinib use, the patient discontinued the medication. However, the disease recurred 6 months later, prompting the initiation of carboplatin therapy.

    DISCUSSION AND CONCLUSION:

    Primary treatment with MAPK kinase inhibitors can lead to tumor regression in brainstem glioma in an adult patient with NF1. We recommend that patients with brainstem glioma undergo biopsy and mutation testing, especially those with an unusually aggressive clinical course.

    DOI： 10.1227/neuprac.0000000000000175

  • Case of Primary Cutaneous Gamma‐Delta T‐Cell Lymphoma in Which Brentuximab Vedotin‐Based Polychemotherapy Failed to Achieve Durable Remission Reviewed

    Yoshinori Muto, Maiko Fujihara, Youichi Ogawa, Naoki Oishi, Yuma Sakamoto, Takashi Okamoto, Hiroshi Mitsui, Keita Kirito, Tetsuo Kondo, Tatsuyoshi Kawamura

    The Journal of Dermatology   52 ( 12 )   2025.9( ISSN：0385-2407  eISSN：1346-8138 )

    　More details

    Authorship：Lead author   Language：English   Publishing type：Research paper (scientific journal)   Publisher：Wiley  

    DOI： 10.1111/1346-8138.17967

  • A deep learning-clinical nomogram hybrid for predicting sentinel lymph node metastasis in melanoma. Reviewed

    Minh-Khang Le, Masataka Kawai, Tetsuo Kondo, Takashi Inozume, Yoshinori Muto, Youichi Ogawa, Shinji Shimada, Takashi Okamoto, Tatsuyoshi Kawamura

    Journal of the European Academy of Dermatology and Venereology : JEADV   2025.9( ISSN：0926-9959  eISSN：1468-3083 )

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    BACKGROUND: Melanoma is a life-threatening skin malignancy, with sentinel lymph node metastasis (SLNM) serving as a critical prognostic factor. While machine and deep learning models using histopathology have focused on melanoma diagnosis, limited efforts have aimed to predict SLNM. OBJECTIVES: This study aimed to develop a collaborative machine and deep learning model that integrates histopathological patches and clinical data to predict SLNM in patients with invasive melanoma, thereby aiding decision-making regarding sentinel lymph node biopsy. METHODS: A total of 78 invasive cutaneous melanoma cases (43 SLNM-positive and 35 SLNM-negative) from the University of Yamanashi Hospital (2007-2022) were divided into training (n = 60) and test (n = 18) datasets. A clustering-constrained attention multiple-instance learning (CLAM) model was developed using haematoxylin and eosin-stained whole-slide images. Among the four CLAM variants, the model using a ResNet50trunc encoder trained on whole-tissue regions (CLAM-R50) demonstrated the best performance and was further integrated with a clinical nomogram. Hybrid modelling was performed using logistic regression, a support vector machine and gradient boosting. RESULTS: CLAM-R50 achieved an area under the receiver operating characteristic curve (AUROC) of 0.875, while the clinical nomogram achieved an AUROC of 0.826 on the test set. The gradient boosting hybrid model, termed the Melanoma Indicative Scorer for Sentinel Lymph node Evaluation (MISSLE), demonstrated the highest AUROC of 0.950 (95% bootstrapped confidence interval (CI): 0.933-1.00) on the test set. CLAM-R50 attention maps identified pale cytoplasm and plasma cell-like tumour cells as predictors of positive SLNM, whereas dense melanin deposition and lymphocyte-like tumour cells predicted negative SLNM. CONCLUSIONS: MISSLE integrates histopathological and clinical data to predict SLNM with high AUROC, surpassing the previous reports and offering a tool for clinical decision-making. Limitations include the single-centre design and predominantly Japanese cohort, limiting generalizability. The code and models are publicly available for external validation.

    DOI： 10.1111/jdv.70000

    PubMed

  • Orofacial Granulomatosis が診断の契機となった Crohn 病の小児の1 例 Reviewed

    武藤容典, 岡本 崇, 三井 広, 小川陽一, 島田眞路, 川村龍吉

    皮膚臨床   67 ( 8 )   999 - 1002   2025.7

    　More details

    Authorship：Lead author   Language：Japanese  

  • High Antigenicity for Treg Cells Confers Resistance to PD-1 Blockade Therapy via High PD-1 Expression in Treg Cells. Reviewed

    Hiroaki Matsuura, Takamasa Ishino, Toshifumi Ninomiya, Kiichiro Ninomiya, Kota Tachibana, Akiko Honobe-Tabuchi, Yoshinori Muto, Takashi Inozume, Youki Ueda, Kadoaki Ohashi, Yoshinobu Maeda, Joji Nagasaki, Yosuke Togashi

    Cancer science   116 ( 5 )   1214 - 1226   2025.5( ISSN：1347-9032  eISSN：1349-7006 )

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    Regulatory T (Treg) cells have an immunosuppressive function, and programmed death-1 (PD-1)-expressing Treg cells reportedly induce resistance to PD-1 blockade therapies through their reactivation. However, the effects of antigenicity on PD-1 expression in Treg cells and the resistance to PD-1 blockade therapy remain unclear. Here, we show that Treg cells gain high PD-1 expression through an antigen with high antigenicity. Additionally, tumors with high antigenicity for Treg cells were resistant to PD-1 blockade in vivo due to PD-1+ Treg-cell infiltration. Because such PD-1+ Treg cells have high cytotoxic T lymphocyte antigen (CTLA)-4 expression, resistance could be overcome by combination with an anti-CTLA-4 monoclonal antibody (mAb). Patients who responded to combination therapy with anti-PD-1 and anti-CTLA-4 mAbs sequentially after primary resistance to PD-1 blockade monotherapy showed high Treg cell infiltration. We propose that the high antigenicity of Treg cells confers resistance to PD-1 blockade therapy via high PD-1 expression in Treg cells, which can be overcome by combination therapy with an anti-CTLA-4 mAb.

    DOI： 10.1111/cas.70029

    PubMed

  • A case of Pott's puffy tumor arising during treatment with lenvatinib and denosumab Reviewed

    Yoshinori Muto, Takashi Okamoto, Youichi Ogawa, Hiroshi Mitsui, Shinji Shimada, Tatsuyoshi Kawamura

    The Journal of Dermatology   2025.1( ISSN：0385-2407  eISSN：1346-8138 )

    　More details

    Authorship：Lead author   Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1111/1346-8138.17420

  • Two cases of hydroa vacciniforme lymphoproliferative disorder in elderly patients: Excellent response to narrow-band ultraviolet B phototherapy. Reviewed

    Ozumi Tomita, Mariko Iwasaki, Hiroshi Mitsui, Yoshinori Muto, Takashi Okamoto, Youichi Ogawa, Shinji Shimada, Tatsuyoshi Kawamura

    JAAD case reports   55   111 - 115   2025.1

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1016/j.jdcr.2024.10.035

    PubMed

  • Efficacy of immune checkpoint inhibitors in patients with metastatic extramammary Paget's disease: Report of two cases and literature review Reviewed

    Yoshinori Muto, Youichi Ogawa, Takashi Okamoto, Hiroshi Mitsui, Shinji Shimada, Tatsuyoshi Kawamura

    The Journal of Dermatology   2024.12

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    DOI： 10.1111/1346-8138.17365

  • 片側性の帯状の神経障害性疼痛を伴ったデング熱の1例 Reviewed

    武藤 容典, 三井 広, 小川 陽一, 田渕 亜希子, 岡本 崇, 島田 眞路, 井上 修, 川村 龍吉

    皮膚科の臨床   65 ( 12 )   1928 - 1932   2023.11

    　More details

    Authorship：Lead author   Language：Japanese  

    DOI： 10.18888/hi.0000004275

  • Immunohistological analysis of pathogenic infiltrates in the epidermis and liver of a patient with toxic epidermal necrolysis accompanied by vanishing bile duct syndrome. Reviewed

    Tomohiro Toyoda, Koji Hashimoto, Youichi Ogawa, Mikiko Tohyama, Yoshinori Muto, Takayuki Murashima, Kei Akao, Koichi Honma, Atsushi Tanaka

    The Journal of dermatology   49 ( 12 )   1343 - 1347   2022.12

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    Toxic epidermal necrolysis (TEN) is a severe cutaneous adverse drug reaction characterized by extensive epidermal detachment, which is reportedly mediated by drug-specific cytotoxic CD8+ T cells, inflammatory monocytes, and neutrophils. Besides the skin, TEN often damages other organs, and it remains unknown whether they are mediated by similar pathogenic cells that cause epidermal damage. We experienced a case who developed TEN complicated with vanishing bile duct syndrome. Immunohistological analysis revealed the infiltration of CD8+ T cells, inflammatory monocytes, and neutrophil extracellular trap-forming neutrophils in the lesions of both the skin and liver with different degree of infiltration of these cells. These data suggest a difference of dominant pathogenic cells between skin and liver of patients with TEN.

    DOI： 10.1111/1346-8138.16576

    PubMed

  • 難治性自己免疫性水疱症におけるリツキシマブの使用経験 Reviewed

    前島 えり, 三井 広, 山本 佐織, 富田 央澄, 武藤 容典, 島田 眞路, 川村 龍吉

    日本皮膚科学会雑誌   132 ( 12 )   2681 - 2687   2022.11

    　More details

    Language：Japanese  

  • 診断に苦慮した左耳下部後面に生じた脂腺癌の1例

    田渕 亜希子, 武藤 容典, 大沼 毅紘, 出口 順啓, 三井 広, 島田 眞路, 川村 龍吉, 櫻井 大樹, 大石 直輝

    日本皮膚科学会雑誌   132 ( 11 )   2539 - 2539   2022.10( ISSN：0021-499X  eISSN：1346-8146 )

    　More details

    Language：Japanese   Publisher：(公社)日本皮膚科学会  

  • Neutrophil Extracellular Traps in Skin Diseases. Reviewed

    Youichi Ogawa, Yoshinori Muto, Manao Kinoshita, Shinji Shimada, Tatsuyoshi Kawamura

    Biomedicines   9 ( 12 )   2021.12

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

    Neutrophils are the primary innate immune cells, and serve as sentinels for invading pathogens. To this end, neutrophils exert their effector functions via phagocytosis, degranulation, reactive oxygen species generation, and neutrophil extracellular trap (NET) release. Pathogens and pathogen-derived components trigger NET formation, leading to the clearance of pathogens. However, NET formation is also induced by non-related pathogen proteins, such as cytokines and immune complexes. In this regard, NET formation can be induced under both non-sterile and sterile conditions. NETs are enriched by components with potent cytotoxic and inflammatory properties, thereby occasionally damaging tissues and cells and dysregulating immune homeostasis. Research has uncovered the involvement of NETs in the pathogenesis of several connective tissue diseases, such as systemic lupus erythematosus, rheumatoid arthritis, and ANCA-associated vasculitis. In dermatology, several skin diseases clinically develop local or systemic sterile pustules and abscesses. The involvement of neutrophils and subsequent NET formation has recently been elucidated in these skin diseases. Therefore, this review highlights the NETs in these neutrophil-associated diseases.

    DOI： 10.3390/biomedicines9121888

    PubMed

  • Case of cutaneous sarcoidosis treated with delgocitinib 0.5% ointment

    Muto Y, Mitsui H, Ogawa Y, Deguchi N, Shimada S, Kawamura T.

    J Dermatol   2021.4

    　More details

    Authorship：Lead author   Language：English  

  • 当科で経験した免疫関連有害事象のまとめ Reviewed

    Skin Cancer   2021.2

    　More details

    Authorship：Lead author,　Last author,　Corresponding author   Language：Japanese  

  • 【"中毒疹"診断のロジックと治療】昆虫が媒介する中毒疹

    川村 龍吉, 保延 亜希子, 武藤 容典

    Derma.   296   25 - 31   2020.5

    　More details

    Language：Japanese  

  • ペムブロリズマブによって誘発された水疱性類天疱瘡の1例

    武藤 容典(山梨県立中央病院), 長田 厚, 塚本 克彦, 島田 眞路, 川村 龍吉

    日本皮膚科学会雑誌   130 ( 3 )   411   2020.3

    　More details

    Authorship：Lead author   Language：Japanese  

  • デング熱の1例

    武藤 容典(山梨大学), 佐野 信也, 長谷部 涼, 保延 亜希子, 大沼 毅紘, 三井 広, 島田 眞路, 川村 龍吉, 井上 修

    日本皮膚科学会雑誌   130 ( 1 )   67   2020.1

    　More details

    Authorship：Lead author   Language：Japanese  

  • IVIG療法により急速進行性間質性肺炎を予防しえた抗MDA-5抗体陽性皮膚筋炎の1例

    武藤 容典(山梨大学 皮膚科), 三井 広, 佐野 信也, 富田 央澄, 小川 陽一, 島田 眞路, 川村 龍吉

    日本皮膚科学会雑誌   129 ( 5 )   1202 - 1203   2019.5

    　More details

    Authorship：Lead author   Language：Japanese  

  • 生検後に消退したポリオーマウイルス抗原陽性Merkel cell carcinoma(MCC)の2例

    武藤 容典(山梨大学), 清水 理惠, 佐野 信也, 保延 亜希子, 三井 広, 島田 眞路, 川村 龍吉, 泉 健太郎, 西江 渉

    日本皮膚科学会雑誌   129 ( 4 )   600   2019.4

    　More details

    Authorship：Lead author   Language：Japanese  

  • Bullous rheumatoid neutrophilic dermatosis(bullous RND)の1例

    武藤 容典(山梨大学), 清水 理惠, 佐野 信也, 保延 亜希子, 三井 広, 島田 眞路, 川村 龍吉, 泉 健太郎, 西江 渉

    日本皮膚科学会雑誌   129 ( 3 )   396   2019.3

    　More details

    Authorship：Lead author   Language：Japanese  

  • 関節エコーが付着部炎の評価に有用であった多中心性細網球症の一例

    武藤 容典(山梨大学), 小川 陽一, 中込 大樹, 小林 惠, 小山 賢介, 波呂 浩孝, 北村 健一郎, 川村 龍吉

    日本皮膚免疫アレルギー学会雑誌   2 ( 1 )   181   2018.10

    　More details

    Authorship：Lead author   Language：Japanese  

  • 山梨大学における肉眼解剖学実習でのTA システムの試み

    北見欣一, 篠原諭史, 武藤容典, 竹田 扇

    医学教育   40 ( 1 )   73 - 84   2009.2

    　More details

    Language：Japanese  

▼display all

Books and Other Publications

  • ―すべての患者さんに安心を― 山梨大学医学部附属病院 地域を支える最新医療

    山梨大学医学部附属病院（ Role： Joint Work皮膚科）

    南々社  2022.11  （  ISBN:4864891508 ）

    　More details

    Total pages：120   Language：Japanese  

    CiNii Books

    ASIN

Presentations

  • 瘢痕性脱毛症3例のまとめ

    保阪樹里、小川陽一、岡本　崇、武藤容典、島田眞路、川村龍吉、田中敬子

    第113回日本皮膚科学会山梨地方会  2026.3  日本皮膚科学会

    　More details

    Event date： 2026.3

    Language：Japanese   Presentation type：Oral presentation(general)  

    Venue：山梨県甲府市   Country：Japan  

  • EBV陽性節性T/NK細胞リンパ腫の皮膚浸潤の1例

    鶴田実奈、武藤容典、小川陽一、島田眞路、川村龍吉（山梨大皮膚科） 河合恵史朗、山田めぐみ、川島一郎、桐戸敬太（同血液・腫瘍内科） 藤原万衣孔、大館 徹、大石直輝、近藤哲夫（同人体病理） 寺本範子（山梨市）

    第113回日本皮膚科学会山梨地方会  2026.3  日本皮膚科学会

    　More details

    Event date： 2026.3

    Language：Japanese   Presentation type：Oral presentation(general)  

    Venue：山梨県甲府市   Country：Japan  

  • 多菌型ハンセン病の1例

    坂本 悠, 武藤容典, 島田眞路, 川村龍吉

    第112回日本皮膚科学会山梨地方会  2025.12  日本皮膚科学会

    　More details

    Language：Japanese   Presentation type：Oral presentation(general)  

    Venue：山梨県甲府市   Country：Japan  

  • 新生児期に皮疹や脳梗塞を認めた色素失調症の姉妹例

    岩崎万里子、木下真直、薬袋里彩、武藤容典、島田眞路、川村龍吉、渡邉祐莉子、長谷部洋平、小泉敬一、矢ヶ崎英昇、藤田未佳、吉岡秀幸、福田佳子

    第112回日本皮膚科学会山梨地方会  2025.12  日本皮膚科学会

    　More details

    Language：Japanese   Presentation type：Oral presentation(general)  

    Venue：山梨県甲府市   Country：Japan  

  • 血球貪食症候群を合併し、治療抵抗性であった 原発性皮膚γδT細胞リンパ腫の1例

    武藤容典, 小川陽一, 島田眞路, 川村龍吉, 坂本勇磨, 桐戸敬太, 藤原万衣孔, 大石直輝

    第89回日本皮膚科学会東部支部学術集会  2025.9  日本皮膚科学会

    　More details

    Language：Japanese  

    Venue：秋田県秋田市   Country：Japan  

  • 原発性皮膚辺縁帯B細胞リンパ腫の小児の1例

    保阪樹里, 武藤容典, 小川陽一, 島田眞路, 川村龍吉, 大石直輝

    第111回日本皮膚科学会山梨地方会  2025.9  日本皮膚科学会

    　More details

    Event date： 2025.9

    Language：Japanese   Presentation type：Oral presentation(general)  

    Venue：山梨県甲府市   Country：Japan  

  • 重症汎発型単純型表皮水疱症の1例

    武藤容典, 鶴田美奈, 小川陽一, 岡本 崇, 三井 広, 島田眞路, 川村龍吉, 小田賢幸, 武市拓也

    第111回日本皮膚科学会山梨地方会  2025.9  日本皮膚科学会

    　More details

    Event date： 2025.9

    Language：Japanese   Presentation type：Oral presentation(general)  

    Venue：山梨県甲府市   Country：Japan  

  • 原発性皮膚γδT細胞リンパ腫の1例

    武藤容典, 小川陽一, 島田眞路, 川村龍吉, 坂本勇磨, 桐戸敬太, 藤原万衣孔, 大石直輝

    第111回日本皮膚科学会山梨地方会  2025.4  日本皮膚科学会

    　More details

    Event date： 2025.4

    Language：Japanese   Presentation type：Oral presentation(general)  

    Venue：山梨県甲府市   Country：Japan  

  • 当科における免疫チェックポイント阻害薬の副作用のまとめ

    武藤容典, 出口順啓, 大沼毅紘, 猪爪隆史, 島田眞路, 川村龍吉

    第37回日本皮膚悪性腫瘍学会  2021.7 

    　More details

    Language：Japanese   Presentation type：Oral presentation(general)  

  • 皮膚サルコイドーシス患者の皮疹へのデルゴシチニブ軟膏の使用経験

    武藤容典、三井広、島田眞路、川村龍吉（山梨大学）

    第97回日本皮膚科学会山梨地方会  2021.2 

    　More details

    Event date： 2021.2

    Language：Japanese  

    Venue：日本  

  • ベキサロテン投与と放射線療法が奏功した菌状息肉症の１例

    武藤容典,出口順啓,松崎公瑠美,大沼毅紘,島田眞路,川村龍吉（山梨大学　皮膚科）

    第96回日本皮膚科学会山梨地方会  2020.12 

    　More details

    Event date： 2020.12

    Language：Japanese  

    Venue：日本  

  • Trichophyton tonsuransの父子感染例

    武藤容典、田中敬子、相川恵子（山梨厚生・皮膚科）、岡藤麻未、澁澤裕史、大城浩子、藤岡薫、小林浩司、池田久剛（同小児科）

    第95回日本皮膚科学会山梨地方会  2020.10 

    　More details

    Event date： 2020.10

    Language：Japanese  

    Venue：日本  

  • 下腿にDiffuse Large B-cell Lymphomaを生じ急激な転帰をとったメトトレキサート関連リンパ増殖性疾患の1例

    武藤容典1,2）、南圭人、長田厚、塚本克彦（1県立中央）、原間紀美絵 （同リウマチ・膠原病内科）、三河貴裕（同感染症科）、坂本勇磨（同血液内科）、川村龍吉（2山梨大学）

    第94回日本皮膚科学会山梨地方会  2019.12 

    　More details

    Event date： 2019.12

    Language：Japanese  

    Venue：日本  

  • ○スぺムブロリズマブによって誘発された水疱性類天疱瘡の1例

    武藤容典、長田厚、塚本克彦（県立中央）、島田眞路、川村龍吉（山梨大学）

    第93回日本皮膚科学会山梨地方会  2019.8 

    　More details

    Event date： 2019.8

    Language：Japanese  

    Venue：日本  

  • IVIG療法により急速進行性間質性肺炎を予防しえた抗MDA-5抗体陽性皮膚筋炎の1例

    武藤容典、三井広、佐野信也、小川陽一、島田眞路、川村龍吉（山梨大学）

    第92回日本皮膚科学会山梨地方会  2019.4 

    　More details

    Event date： 2019.4

    Language：Japanese  

    Venue：日本  

  • ㋜デング熱の一例

    武藤容典、佐野信也、長谷部涼、保延亜希子、大沼毅紘、三井広、島田眞路、川村龍吉 （山梨大学）、井上修（同 感染制御部）

    第91回日本皮膚科学会山梨地方会  2018.12 

    　More details

    Event date： 2018.12

    Language：Japanese  

    Venue：日本  

▼display all

Awards

  • CDLS賞

    2025.10   日本皮膚科学会 Clinical Dermatology Leadership Seminar 2025  

    日本皮膚科学会キャリア支援委員会

    　More details

    Award type：Award from Japanese society, conference, symposium, etc.  Country：Japan

Teaching Experience (On-campus)

  • がん免疫療法

    2025Year  Type of subject：Professional education (undergraduate)

  • 4年性「臨床推論」　YMS-(6)-(2) 症候：発疹

    2025Year  Type of subject：Professional education (undergraduate)

  • 悪性黒色腫

    2025Year  Type of subject：Professional education (undergraduate)

  • 皮膚悪性リンパ腫と皮膚の間葉系腫瘍

    2025Year  Type of subject：Professional education (undergraduate)

Teaching Experience

  • 皮膚悪性リンパ腫と皮膚の間葉系腫瘍

    2024.5
    Institution：山梨大学

    　More details

    Level：Undergraduate (specialized) 

  • 悪性黒色腫

    2023.11
    Institution：山梨大学

    　More details

    Level：Undergraduate (specialized) 

  • 4年生「臨床推論」 【 YMS-(6)-(2)　症候：発疹】

    2023.10
    Institution：山梨大学

    　More details

    Level：Undergraduate (specialized) 

  • がん免疫療法

    2022.11
    Institution：山梨大学

    　More details

    Level：Undergraduate (specialized) 

Other undergraduate student guidance

  • 2025

    Hospital clinical training - total time：3hours

  • 2025

    Hospital clinical training - total time：3hours

  • 2025

    Class teacher - period： 2020

Other educational achievements

  • Pre CC-OSCE 内部評価者　2025/10/4

    2025

Social Activities

  • 50th JSID

    Role(s)： Organizing member

    Japanese society of investive dermatology  2025.12

  • 皮膚の日健診

    Role(s)： Organizing member

    山梨県皮膚科医会  2025.11

Professional Memberships

  • 日本皮膚科学会

  • 皮膚悪性腫瘍学会